ARDX
Ardelyx Inc
Price:  
5.56 
USD
Volume:  
3,178,119.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

Ardelyx EV/EBITDA

-176.4%
Upside

As of 2025-02-06, the EV/EBITDA ratio of Ardelyx Inc (ARDX) is -23.09. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Ardelyx's latest enterprise value is 1,370.16 mil USD. Ardelyx's TTM EBITDA according to its financial statements is -59.33 mil USD. Dividing these 2 quantities gives us the above Ardelyx EV/EBITDA ratio.

Note: valuation result may not be accurate due to the company's negative EBITDA.

Range Selected
Trailing P/E multiples 14.1x - 17.1x 16.0x
Forward P/E multiples 14.4x - 19.3x 16.1x
Fair Price (3.84) - (4.51) (4.25)
Upside -169.1% - -181.1% -176.4%
5.56 USD
Stock Price
(4.25) USD
Fair Price

Ardelyx EV/EBITDA - Historical EV/EBITDA Data

Date EV/EBITDA
2025-01-24 -22.85
2025-01-23 -22.89
2025-01-22 -21.06
2025-01-21 -20.50
2025-01-17 -20.90
2025-01-16 -21.50
2025-01-15 -22.26
2025-01-14 -23.33
2025-01-13 -24.37
2025-01-10 -21.14
2025-01-08 -22.22
2025-01-07 -22.50
2025-01-06 -20.86
2025-01-03 -20.74
2025-01-02 -21.34
2024-12-31 -21.14
2024-12-30 -21.86
2024-12-27 -21.70
2024-12-26 -20.10
2024-12-24 -19.42
2024-12-23 -19.18
2024-12-20 -20.14
2024-12-19 -19.62
2024-12-18 -19.30
2024-12-17 -19.50
2024-12-16 -22.42
2024-12-13 -21.74
2024-12-12 -21.82
2024-12-11 -22.14
2024-12-10 -21.94
2024-12-09 -21.94
2024-12-06 -23.73
2024-12-05 -22.85
2024-12-04 -23.17
2024-12-03 -22.85
2024-12-02 -23.01
2024-11-29 -23.53
2024-11-27 -23.61
2024-11-26 -22.26
2024-11-25 -21.86
2024-11-22 -22.10
2024-11-21 -21.34
2024-11-20 -20.54
2024-11-19 -20.02
2024-11-18 -20.70
2024-11-15 -20.74
2024-11-14 -19.70
2024-11-13 -18.86
2024-11-12 -19.22
2024-11-11 -20.44